论文部分内容阅读
由血栓引起的心血管系统疾病严重威胁着人类健康，临床上急需一种溶栓效果好、副作用小的药物。尿型纤溶酶原激活剂（ｕ－ＰＡ）作为一种有前景的溶栓药物已受到国内外普遍重视，我所构建的表达重组人ｕ－ＰＡ的ＣＨＯ工程细胞（ＣＬ－１１Ｇ株）培养上清经纯化可获得含约...
Cardiovascular diseases caused by thrombus pose a serious threat to human health and urgently require a drug that has good thrombolytic effect and low side effects. Urinary type plasminogen activator (u-PA) as a promising thrombolytic drug has received widespread attention at home and abroad. The CHO engineering cell (CL-11G strain) expressing recombinant human u-PA constructed by us Supernatant purified to obtain containing about ...